| |
|
|
|
Genmark Diagnostics  
|
|
15.45 0.03 (0%) |
01-25 16:00 |
|
Open: |
14.18 |
Pre close: |
15.42 |
Target:
|
20.53
|
|
High: |
15.62 |
Low: |
14.18 |
Resistance:
|
17.58
20.53
|
|
Volume: |
1,810,008 |
Market Cap: |
1108M |
Support:
|
14.76
 13.01
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
15.01
|
MACD |
MACD(12,26):
|
0.24 |
|
MA(20): |
15.12 |
Signal(12,26,9): |
0.31  |
|
MA(100): |
13.46 |
Stochastic Oscillator |
%K(14,3):
|
35.04 |
|
MA(250): |
11.58 |
%D(3): |
29.38 |
|
Average Volume(K) |
3-Month: |
81866
|
52-Week |
High:
|
20.88 |
|
10-Days: |
108960 |
Low: |
3.36 |
|
RSI |
RSI(14):
|
56.52 |
Change(%): |
179.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.390 |
Return on Equity (ttm) |
-49.2 |
Shares Out. (M) |
71.72 |
|
EPS Est. Current Year |
-1.070 |
Return on Assets (ttm) |
-6.1 |
Shares Float (M) |
58.03 |
|
EPS Est. Next Year |
-0.690 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.29 |
|
EPS Est. Next Quarter |
-0.140 |
Qtrly Rev. Growth |
103.9 |
% Held by Institutions |
98.73 |
|
Forward EPS |
-0.820 |
Gross Profit (p.s.) |
0.399 |
Shares Short (K) |
6860 |
|
Book Value (p.s.) |
1.320 |
EBITDA (p.s.) |
-0.113 |
P/E |
-39.62 |
|
Sales Per Share |
2.073 |
Qtrly Earnings Growth |
0.00 |
P/BV |
11.70 |
|
Profit Margin |
-16.96 |
Operating Cash Flow
(M) |
-2.68 |
P/S |
7.45 |
|
Operating Margin |
-9.87 |
Levered Free Cash Flow
(M) |
4.90 |
P/CF |
-413.46 |
|
|
|
|
|
|
